| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 9,378 | 938 | 8,440 |
| Grantee's Name | Grantee's Address | Grant Date | Grant Amount | Grant Purpose | Amount Expended By Grantee | Any Diversion By Grantee? | Dates of Reports By Grantee | Date of Verification | Results of Verification |
|---|---|---|---|---|---|---|---|---|---|
|
ROIVANT SCIENCES LTD |
20-22 BEDFORD ROW LONDON WC1 RJS UK |
2018-11-15 | 200,015 | DIRECT EQUITY PRI - AN INVESTMENT IN ROIVANT SCIENCES LTD. IS MAINTAINED BY THE FOUNDATION EFFECTIVE MARCH 2017. THIS INVESTMENT ALIGNS SQUARELY WITH ONE OF THE FIVE MAJOR PROGRAM ARMS OF THE FOUNDATION: BELIEF THAT RESEARCH AND DEVELOPMENT OF LIFE SCIENCE KNOWLEDGE HOLDS THE PROMISE TO SUBSTANTIALLY IMPROVE THE LIVES OF ALL INDIVIDUALS. THE GRANT WAS MADE IN A PRIOR PERIOD. NO CURRENT YEAR GRANTS WERE MADE. | 200,015 | NO | 12/31/2018, 12/31/2019, 1/18/2021 |
| Identifier | Return Reference | Explanation |
|---|---|---|
| PART VII-A LINE 5A(4) AND C | THE GRANT NOTED WAS MADE IN A PRIOR PERIOD FOR A DIRECT EQUITY PROGRAM RELATED INVESTMENT. NO CURRENT YEAR GRANTS WERE MADE TO THE PROGRAM RELATED INVESTMENT. |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 77,800 SHARES ISHARES CORE US AGG BOND ETF | 9,195,182 | 9,195,182 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 13,200 SHS SPDR S&P 500 ETF | 4,935,216 | 4,935,216 |
| 142,953 SHARES ISHARES MSCI ACWI ETF | 12,968,696 | 12,968,696 |
| 30,100 SHARES MSCI SINGAPORE | 646,548 | 646,548 |
| 100,700 SHARES OWL ROCK CAPITAL CORP | 1,274,862 | 1,274,862 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| CITADEL 1108 | FMV | 16,865,672 | 16,865,672 |
| QUELLOS 1004 | FMV | 9,902,315 | 9,902,315 |
| VRGOF 1804 | FMV | 1,931,075 | 1,931,075 |
| VOLOF 1910 | FMV | 6,313,135 | 6,313,135 |
| ILLUMIO 1704 | FMV | 2,000,000 | 2,000,000 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL FEES | 705 | 71 | 635 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| PROGRAM RELATED INVESTMENT - ROIVANT SCIENCES LTD | 27,570,661 | 27,386,892 | 27,386,892 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| SUBSCRIPTION EXPENSE | 215 | 0 | 215 | |
| LICENSE EXPENSE | 25 | 0 | 25 |
| Description | Amount |
|---|---|
| UNREALIZED GAIN | 9,450,207 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXCISE TAXES | 52,000 | 0 | 0 | |
| FOREIGN TAXES | 195 | 195 | 0 |